Search
for
Sort by
Research 31–60 of 508
- Effect of 5α-Reductase Inhibitors on Sexual Function: A Meta-Analysis and Systematic Review of Randomized Controlled Trials
- 5α-Reductase Type 2 Regulates Glucocorticoid Action and Metabolic Phenotype in Human Hepatocytes
- Inhibitors of 5α-Reductase in the Treatment of Benign Prostatic Hyperplasia
- An update of anti-viral treatment of COVID-19
- Steroidal 5α-reductase and 17α-hydroxylase/17,20-lyase (CYP17) inhibitors useful in the treatment of prostatic diseases
- Persistent erectile dysfunction in men exposed to the 5α-reductase inhibitors, finasteride, or dutasteride
- Anti‐androgens may protect against severe COVID‐19 outcomes: results from a prospective cohort study of 77 hospitalized men
- Actions of 5α-reductase inhibitors on the epididymis
- Preparation and characterization of dutasteride-loaded nanostructured lipid carriers coated with stearic acid-chitosan oligomer for topical delivery
- 5 Alpha-reductase inhibitors: whatʼs new?
- Clinical application of 5α-reductase inhibitors
- Human type 3 5α-reductase is expressed in peripheral tissues at higher levels than types 1 and 2 and its activity is potently inhibited by finasteride and dutasteride
- Dutasteride
- 5-α-Reductase inhibitors for prostate cancer chemoprevention: an updated Cochrane systematic review
- Early Antiandrogen Therapy With Dutasteride Reduces Viral Shedding, Inflammatory Responses, and Time-to-Remission in Males With COVID-19: A Randomized, Double-Blind, Placebo-Controlled Interventional Trial (EAT-DUTA AndroCoV Trial – Biochemical)
- Dutasteride improves male pattern hair loss in a randomized study in identical twins
- 5-Alpha reductase deficiency
- Dutasteride: a review of current data on a novel dual inhibitor of 5alpha reductase.
- Five-alpha-reductase Inhibitors for prostate cancer prevention.
- Side Effects of 5‐Alpha Reductase Inhibitors: A Comprehensive Review
- Intracrine and Myotrophic Roles of 5α-Reductase and Androgens
- Androgens in women
- Neuroactive gonadal drugs for neuroprotection in male and female models of Parkinson's disease
- Investigation of the Plausibility of 5-Alpha-Reductase Inhibitor Syndrome
- In Vitro and In Vivo Skin Distribution of 5α-Reductase Inhibitors Loaded Into Liquid Crystalline Nanoparticles
- Adverse Effects and Safety of 5-alpha Reductase Inhibitors (Finasteride, Dutasteride): A Systematic Review.
- Long-term safety and efficacy of dutasteride in the treatment of male patients with androgenetic alopecia
- Dutasteride reduces alcohol’s sedative effects in men in a human laboratory setting and reduces drinking in the natural environment
- The effectiveness of finasteride and dutasteride used for 3 years in women with androgenetic alopecia
- Male Breast Cancer and 5α-Reductase Inhibitors Finasteride and Dutasteride